156 related articles for article (PubMed ID: 35435334)
1. The In Vitro Differentiation of Human CD141+CLEC9A+ Dendritic Cells from Mobilized Peripheral Blood CD34+ Hematopoietic Stem Cells.
Swartz AM; Nair SK
Curr Protoc; 2022 Apr; 2(4):e410. PubMed ID: 35435334
[TBL] [Abstract][Full Text] [Related]
2. Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141
Masterman KA; Haigh OL; Tullett KM; Leal-Rojas IM; Walpole C; Pearson FE; Cebon J; Schmidt C; O'Brien L; Rosendahl N; Daraj G; Caminschi I; Gschweng EH; Hollis RP; Kohn DB; Lahoud MH; Radford KJ
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32737142
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Generation of Human XCR1(+) Dendritic Cells from CD34(+) Hematopoietic Progenitors.
Balan S; Dalod M
Methods Mol Biol; 2016; 1423():19-37. PubMed ID: 27142006
[TBL] [Abstract][Full Text] [Related]
4. Human CD141
Lee YS; O'Brien LJ; Walpole CM; Pearson FE; Leal-Rojas IM; Masterman KA; Atkinson V; Barbour A; Radford KJ
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737342
[TBL] [Abstract][Full Text] [Related]
5. Human CD141
Kim SJ; Kim G; Kim N; Chu H; Park BC; Yang JS; Han SH; Yun CH
Cytotherapy; 2019 Oct; 21(10):1049-1063. PubMed ID: 31447319
[TBL] [Abstract][Full Text] [Related]
6. Clinically applicable CD34
van Eck van der Sluijs J; van Ens D; Thordardottir S; Vodegel D; Hermens I; van der Waart AB; Falkenburg JHF; Kester MGD; de Rink I; Heemskerk MHM; Borst J; Schaap NPM; Jansen JH; Xiao Y; Dolstra H; Hobo W
Cancer Immunol Immunother; 2021 Nov; 70(11):3167-3181. PubMed ID: 33796917
[TBL] [Abstract][Full Text] [Related]
7. T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A
Koster BD; López González M; van den Hout MF; Turksma AW; Sluijter BJ; Molenkamp BG; van Leeuwen PA; Vosslamber S; Scheper RJ; van den Eertwegh AJ; van den Tol MP; Jordanova EJ; de Gruijl TD
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737341
[TBL] [Abstract][Full Text] [Related]
8. Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer.
Mastelic-Gavillet B; Sarivalasis A; Lozano LE; Wyss T; Inoges S; de Vries IJM; Dartiguenave F; Jichlinski P; Derrè L; Coukos G; Melero I; Harari A; Romero P; Viganó S; Kandalaft LE
Eur J Cancer; 2020 Aug; 135():173-182. PubMed ID: 32590296
[TBL] [Abstract][Full Text] [Related]
9. Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells.
Kirkling ME; Cytlak U; Lau CM; Lewis KL; Resteu A; Khodadadi-Jamayran A; Siebel CW; Salmon H; Merad M; Tsirigos A; Collin M; Bigley V; Reizis B
Cell Rep; 2018 Jun; 23(12):3658-3672.e6. PubMed ID: 29925006
[TBL] [Abstract][Full Text] [Related]
10. BDCA3 expression is associated with high IFN-λ production by CD34(+)-derived dendritic cells generated in the presence of GM-CSF, IL-4, and/or TGF-β.
van der Aa E; van de Laar L; Janssen HL; van Montfoort N; Woltman AM
Eur J Immunol; 2015 May; 45(5):1471-81. PubMed ID: 25616220
[TBL] [Abstract][Full Text] [Related]
11. Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling.
Makino K; Long MD; Kajihara R; Matsueda S; Oba T; Kanehira K; Liu S; Ito F
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35101945
[TBL] [Abstract][Full Text] [Related]
12. The equivalents of human blood and spleen dendritic cell subtypes can be generated in vitro from human CD34(+) stem cells in the presence of fms-like tyrosine kinase 3 ligand and thrombopoietin.
Proietto AI; Mittag D; Roberts AW; Sprigg N; Wu L
Cell Mol Immunol; 2012 Nov; 9(6):446-54. PubMed ID: 23085949
[TBL] [Abstract][Full Text] [Related]
13. Allograft Inflammatory Factor-1 Governs Hematopoietic Stem Cell Differentiation Into cDC1 and Monocyte-Derived Dendritic Cells Through IRF8 and RelB
Elizondo DM; Brandy NZD; da Silva RLL; Haddock NL; Kacsinta AD; de Moura TR; Lipscomb MW
Front Immunol; 2019; 10():173. PubMed ID: 30800127
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
Choi D; Perrin M; Hoffmann S; Chang AE; Ratanatharathorn V; Uberti J; McDonagh KT; Mulé JJ
Clin Cancer Res; 1998 Nov; 4(11):2709-16. PubMed ID: 9829733
[TBL] [Abstract][Full Text] [Related]
15. Efficient generation of CD34+ progenitor-derived dendritic cells from G-CSF-mobilized peripheral mononuclear cells does not require hematopoietic stem cell enrichment.
Paczesny S; Li YP; Li N; Latger-Cannard V; Marchal L; Ou-Yang JP; Bordigoni P; Stoltz JF; Eljaafari A
J Leukoc Biol; 2007 Apr; 81(4):957-67. PubMed ID: 17229904
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of Human Induced Pluripotent Stem Cells (iPS Cells) and Embryonic Stem Cells (ES Cells) into Dendritic Cell (DC) Subsets.
Sontag S; Förster M; Seré K; Zenke M
Bio Protoc; 2017 Aug; 7(15):e2419. PubMed ID: 34541147
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the immunogenicity of cancer vaccines by harnessing CLEC9A.
Lahoud MH; Radford KJ
Hum Vaccin Immunother; 2022 Dec; 18(1):1873056. PubMed ID: 33625943
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
[TBL] [Abstract][Full Text] [Related]
19. Efficient ex vivo generation of human dendritic cells from mobilized CD34+ peripheral blood progenitors.
Ohishi K; Katayama N; Mitani H; Araki H; Masuya M; Suzuki H; Hoshino N; Miyashita H; Nishii K; Kageyama S; Minami N; Shiku H
Int J Hematol; 2001 Oct; 74(3):287-96. PubMed ID: 11721965
[TBL] [Abstract][Full Text] [Related]
20. Increased tubulointerstitial recruitment of human CD141(hi) CLEC9A(+) and CD1c(+) myeloid dendritic cell subsets in renal fibrosis and chronic kidney disease.
Kassianos AJ; Wang X; Sampangi S; Muczynski K; Healy H; Wilkinson R
Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1391-401. PubMed ID: 24049150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
